AL
Rating #12
Alphabet
Portfolio value
Stocks
Performance
1 Year
+121.29%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Top10 stocks: 94.04% of the portfolio
Company Name | Primary Industry | Avg. price paid | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 ![]() CME | Security & Commodity Brokers | $295.35 | New Buy +100.00% | 3.48M | $1.03B | 25.63% 25.63ppt | 0.97% | 1 Quarter | Q1 2026 | |
2 ![]() PL | Broadcasting Equipment | $8.19 | Add +10.35% | 35.25M | $985.21M | 24.53% 0.12ppt | 11.11% | 18 Quarters | Q1 2026 | |
3 ![]() ASTS | Other Communications Services | $22.74 | 0.00% | 8.94M | $741.15M | 18.46% -6.72ppt | 3.49% | 5 Quarters | Q1 2025 | |
4 ![]() RVMD | Biological products | $28.69 | Cut -1.57% | 3.29M | $320.20M | 7.97% -2.35ppt | 1.73% | 10 Quarters | Q1 2026 | |
5 ![]() ARM | Semiconductors | $53.52 | 0.00% | 1.96M | $296.63M | 7.39% -0.92ppt | 0.18% | 11 Quarters | Q3 2023 | |
6 ![]() FRSH | Prepackaged Software | $18.63 | 0.00% | 16.21M | $130.14M | 3.24% -4.45ppt | 5.57% | 18 Quarters | Q3 2024 | |
7 ![]() PATH | Prepackaged Software | $67.93 | 0.00% | 7.03M | $78.08M | 1.94% -2.52ppt | 1.31% | 20 Quarters | Q4 2023 | |
8 ![]() TEM | Computer Programming & Data | $33.34 | 0.00% | 1.55M | $70.14M | 1.75% -1.80ppt | 0.89% | 8 Quarters | Q2 2024 | |
- | $21.34 | New Buy +100.00% | 3.13M | $66.69M | 1.66% 1.66ppt | 0.00% | 1 Quarter | Q1 2026 | ||
10 ![]() GTLB | Prepackaged Software | $52.96 | 0.00% | 2.72M | $58.96M | 1.47% -2.50ppt | 1.64% | 16 Quarters | Q1 2025 | |
11 ![]() PRME | Biotechnology | $15.12 | 0.00% | 16.56M | $57.64M | 1.44% -0.79ppt | 11.13% | 14 Quarters | Q3 2025 | |
12 ![]() LIFE | - | $11.17 | New Buy +100.00% | 3.77M | $42.11M | 1.05% 1.05ppt | 0.00% | 1 Quarter | Q1 2026 | |
13 ![]() MAZE | Biological products | $11.01 | 0.00% | 1.39M | $41.45M | 1.03% -1.20ppt | 3.23% | 5 Quarters | Q4 2025 | |
14 ![]() BBOT | Blank Checks | $11.58 | 0.00% | 2.82M | $25.27M | 0.63% -0.74ppt | 9.06% | 3 Quarters | Q3 2025 | |
15 ![]() RLAY | Biological products | $41.71 | Cut -0.29% | 1.56M | $15.56M | 0.39% -0.13ppt | 0.91% | 23 Quarters | Q1 2026 | |
16 ![]() GLUE | Biological products | $22.70 | Cut -8.14% | 684.28K | $11.26M | 0.28% -0.17ppt | 1.04% | 20 Quarters | Q1 2026 | |
17 ![]() VERA | Pharmaceutical Pres | $13.26 | 0.00% | 241.26K | $9.71M | 0.24% -0.23ppt | 0.38% | 20 Quarters | Q1 2024 | |
18 ![]() SANA | Biological products | $33.47 | 0.00% | 2.81M | $8.10M | 0.20% -0.24ppt | 1.11% | 21 Quarters | Q1 2021 | |
19 ![]() BEAM | Biological products | $18.00 | 0.00% | 321.60K | $7.66M | 0.19% -0.15ppt | 0.33% | 25 Quarters | Q3 2021 | |
20 ![]() LYEL | Pharmaceutical Pres | $8.84 | 0.00% | 293.26K | $5.88M | 0.15% -0.20ppt | 1.72% | 4 Quarters | Q2 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers